Nuveen’s CureVac CVAC Stock Holding History

Nuveen’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-61,831	Closed	-$331K	–	3259
2025 Q3	$331K	Hold	61,831	–	–	﹤0.01%	3029
2025 Q2	$332K	Sell	61,831 -21,388	-26%	-$84.8K	﹤0.01%	3011
2025 Q1	$232K	Hold	83,219	–	–	﹤0.01%	3095
2024 Q4	$260K	Hold	83,219	–	–	﹤0.01%	3155
2024 Q3	$257K	Hold	83,219	–	–	﹤0.01%	3179
2024 Q2	$276K	Hold	83,219	–	–	﹤0.01%	3168
2024 Q1	$256K	Hold	83,219	–	–	﹤0.01%	3130
2023 Q4	$354K	Buy	+83,219	New	+$451K	﹤0.01%	3108
2022 Q2	–	Sell	-120,588	Closed	-$2.35M	–	3300
2022 Q1	$2.35M	Buy	120,588 +9,792	+9%	+$196K	﹤0.01%	2426
2021 Q4	$3.8M	Buy	110,796 +1,039	+0.9%	+$41.8K	﹤0.01%	2266
2021 Q3	$6M	Sell	109,757 -45,341	-29%	-$2.73M	﹤0.01%	2111
2021 Q2	$11.4M	Buy	+155,098	New	+$15.5M	﹤0.01%	1787

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Nuveen's CVAC Position: Q4 2025 in Review

Nuveen sold out of CureVac (CVAC) in Q4 2025, closing a stake of 61,831 shares — an estimated $331K sold.

Nuveen first reported a position in CVAC in Q2 2021 and held it in 12 quarters. The position peaked at $11.4M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Nuveen reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Nuveen sold 61,831 CureVac shares in Q4 2025, an estimated $331K.
Nuveen first reported a position in CureVac in Q2 2021 and held it in 12 quarters.
Nuveen's CureVac position peaked at $11.4M in Q2 2021.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.